top of page

Familial chylomicronemia syndrome

Basic Information

Market Information

Currently Approved Drugs 

Image 1 

Chart

Image 2 

Chart

Current Catalysts in AMP Databases

IONS

IONIS-APOCIII-LRx (Olezarsen)

FCS (Familial chylomicronemia syndrome)

NDA

Early 2024

ARWR

Plozasiran (ARO-APOC3)

FCS (Familial Chylomicronemia Syndrome)

Phase 3

Q3 2024

bottom of page